This low-cost exchange-traded fund offers an attractive yield while diversifying risk.
Russell indexes rebalancing overshadowed by Brexit result
Hengrui Therapeutics Inc. Announces $100 Million Investment from HR Bio Holdings Ltd. for Global Clinical Development
Dividend strategies can look and behave differently from one another depending on how they manage the trade-off between income and dividend growth.
There are broader, cheaper options than this 2000-era world-stock ETF.
Global Thalassemia Market Report: 2016 Edition - Gene Therapy for Curing Thalassemia/ Advances in Iron Chelation Therapy / Fetal Hemoglobin Inducers - Research and Markets
The firm's quantitative fund expansion seems consistent with its identity for reasonably priced, low-turnover investment strategies.
The tiny stock that just jumped more than 500%
Pershing Square Holdings, Ltd. Releases Monthly Net Asset Value and Performance Report for May 2016
UPDATE: This bear market sign just got more friendly to stock bulls